Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10.0Revenue $M0.1Net Margin (%)-140,347.4Altman Z-Score-352.3
Enterprise Value $M10.1EPS $-2.3Operating Margin %-100,347.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-145.0Pre-tax Margin (%)-140,326.3Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-29.0Quick Ratio0.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-8.7Current Ratio0.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-319.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-522.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M11.1ROIC % (ttm)-427.8Gross Margin Increase y-yN

Gurus Latest Trades with ECTE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ECTECharles Brandes 2015-09-30 Sold Out $1.39 - $1.8
($1.59)
$ 0.90-43%Sold Out0
ECTECharles Brandes 2015-03-31 Buy $1.48 - $2.95
($2.34)
$ 0.90-62%New holding34,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ECTE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ECTE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHOENBART ALAN WAYNECFO AND SECRETARY 2015-05-20Buy2,500$1.44-37.5view
Hollander Scott WaynePRESIDENT AND CEO 2015-05-20Buy8,000$1.48-39.19view
Nordlicht Mark10% Owner 2014-06-30Buy65,739$2.2-59.09view
Nordlicht Mark10% Owner 2014-06-26Buy17,300$2.2-59.09view
Nordlicht Mark10% Owner 2014-06-24Buy16,961$2.2-59.09view
GOLDBERG MICHAEL M 2014-02-28Sell0$0-59.09view
Nordlicht Mark10% Owner 2013-12-10Buy69,569$2.75-67.27view
Platinum Partners Value Arbitr10% Owner 2013-07-11Sell0$0-67.27view
Doman Robert FDirector 2013-03-22Buy15,000$0.812.5view
GRIECO WILLIAMDirector 2013-03-21Buy30,000$0.7618.42view

Quarterly/Annual Reports about ECTE:

    News about ECTE:

    Articles On GuruFocus.com
    5 Healthcare Picks for 2012 Mar 21 2012 

    More From Other Websites
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Feb 10 2016
    Echo Therapeutics Announces Conference Call and Webcast to Provide a Corporate Update Feb 08 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Feb 03 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Feb 01 2016
    Echo Therapeutics Announces Entry Into Definitive Agreements for the Sale of up to $5.1 Million of... Feb 01 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Jan 12 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jan 08 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Jan 06 2016
    Echo Therapeutics Appoints Elazer Edelman, M.D., Ph.D. to Board of Directors Jan 04 2016
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Dec 28 2015
    Echo Therapeutics Appoints Elazer Edelman, M.D., Ph.D. to Board of Directors Dec 28 2015
    Echo Therapeutics, Inc. Announces Third Quarter 2015 Financial Results and Provides Corporate Update Dec 09 2015
    ECHO THERAPEUTICS, INC. Financials Dec 08 2015
    Echo Therapeutics, Inc. Announces Third Quarter 2015 Financial Results and Provides Corporate Update Nov 16 2015
    ECHO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report Nov 16 2015
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Oct 29 2015
    Echo Therapeutics' Continuous Glucose Monitoring System to be Profiled on Worldwide Business with... Oct 21 2015
    Echo Therapeutics' Continuous Glucose Monitoring System to be Profiled on Worldwide Business with... Oct 15 2015
    ECHO THERAPEUTICS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Material... Sep 30 2015
    Echo Therapeutics, Inc. Earnings Q2, 2015 Sep 16 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK